DOT1L and leukemia: Our observation that treatment of SEM cells with DOT1L inhibitors appears to cooperate with ABT-199 treatment provides an interesting proof of principle that DOT1L inhibitors could potentially be used to sensitize MLLr leukemias to treatment with ABT-199.